Periodic Reporting for period 1 - GIPTRAP (Therapeutic potential of recombinant antibodies to neutralize immunogenic peptides in celiac disease)

Celiac disease consists of an autoimmune response triggered by dietary gluten exposition in genetically predisposed individuals, around 1% of the population. To this day, the only effective treatment is a permanent gluten free diet (GFD). However, a fully GFD is difficult to...